PL3746114T3 - Kompozycje do zastosowania w leczeniu zaćmy - Google Patents

Kompozycje do zastosowania w leczeniu zaćmy

Info

Publication number
PL3746114T3
PL3746114T3 PL19702553.9T PL19702553T PL3746114T3 PL 3746114 T3 PL3746114 T3 PL 3746114T3 PL 19702553 T PL19702553 T PL 19702553T PL 3746114 T3 PL3746114 T3 PL 3746114T3
Authority
PL
Poland
Prior art keywords
compositions
treat cataract
cataract
treat
Prior art date
Application number
PL19702553.9T
Other languages
English (en)
Inventor
Elisabeth VAN AKEN
Joris Delanghe
Nico Callewaert
Loes VAN SCHIE
Original Assignee
Universiteit Gent
Vib Vzw
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiteit Gent, Vib Vzw filed Critical Universiteit Gent
Publication of PL3746114T3 publication Critical patent/PL3746114T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
    • C12Y207/01171—Protein-fructosamine 3-kinase (2.7.1.171)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL19702553.9T 2018-01-30 2019-01-28 Kompozycje do zastosowania w leczeniu zaćmy PL3746114T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18154064 2018-01-30
PCT/EP2019/051961 WO2019149648A1 (en) 2018-01-30 2019-01-28 Compositions for use to treat cataract

Publications (1)

Publication Number Publication Date
PL3746114T3 true PL3746114T3 (pl) 2023-01-16

Family

ID=61094279

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19702553.9T PL3746114T3 (pl) 2018-01-30 2019-01-28 Kompozycje do zastosowania w leczeniu zaćmy

Country Status (7)

Country Link
US (1) US11478499B2 (pl)
EP (1) EP3746114B1 (pl)
JP (1) JP7213891B2 (pl)
CA (1) CA3088239A1 (pl)
ES (1) ES2917628T3 (pl)
PL (1) PL3746114T3 (pl)
WO (1) WO2019149648A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020053188A1 (en) 2018-09-14 2020-03-19 Universiteit Gent Compositions for use to treat advanced glycation end products-dependent ocular diseases
WO2022107735A1 (ja) * 2020-11-17 2022-05-27 株式会社林原 水晶体硬度調節剤
ES2994793T3 (en) * 2021-03-08 2025-01-31 Univ Gent Treatment of eye diseases with fructosyl-amino acid oxidase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003222533A1 (en) * 2002-04-29 2003-11-17 Protemix Corporation Limited Proteins with deglycating activities and methods of using same
JP2011510908A (ja) * 2007-06-11 2011-04-07 シャネル パフュームズ ビューテ 皮膚の老化を抑制するためのfn3kおよび/またはfn3krpの発現を刺激するための有効薬剤の使用
BR112014010091B1 (pt) * 2011-10-27 2022-11-08 Wellstat Ophthalmics Corporation Ácido nucleico, vetor viral, preparação farmacêutica, uso destes, método para produção de uma proteína rdcvf, e método in vitro ou ex vivo de secreção de uma proteína rdcvf a partir de uma célula
WO2017078953A1 (en) * 2015-11-06 2017-05-11 Accuitis Pharmaceuticals, Inc. Use of proteasome inhibitors to treat ocular disorders

Also Published As

Publication number Publication date
US20210030780A1 (en) 2021-02-04
WO2019149648A1 (en) 2019-08-08
JP2021515803A (ja) 2021-06-24
EP3746114A1 (en) 2020-12-09
EP3746114B1 (en) 2022-05-04
CA3088239A1 (en) 2019-08-08
US11478499B2 (en) 2022-10-25
JP7213891B2 (ja) 2023-01-27
ES2917628T3 (es) 2022-07-11

Similar Documents

Publication Publication Date Title
GB2585978B (en) Therapeutic compositions
ZA201803530B (en) Compounds and compositions useful for treating disorders related to ntrk
ZA201801881B (en) Compounds and compositions useful for treating disorders related to ntrk
ZA202006610B (en) Compositions for the treatment of skin conditions
GB201715639D0 (en) Compositions for wound treatment
SG11201705093UA (en) Composition for treating il-6-related diseases
IL246791A0 (en) Compositions and methods for treating eye diseases
ZA202007055B (en) Compositions for the treatment of skin conditions
IL258032A (en) Compounds and preparations for the treatment of ocular disorders
IL249938B (en) Preparations of antiviral substances for preventive treatment
IL261774B (en) Preparations for the treatment of skin problems
LT3573620T (lt) Kompozicijos, skirtos hipertenzijos gydymui
IL276921A (en) Methods for changing body composition
EP3160460A4 (en) Ketobutyrate compounds and compositions for treating age-related symptoms and diseases
GB201707462D0 (en) Ocular compositions
IL249640A0 (en) Preparations for the treatment of nosebleeds
PL3493823T4 (pl) Składnik na bazie postbiotyki do leczenia zapalenia oka
SG11202008959RA (en) Composition for improving skin conditions
SG11202006144XA (en) Composition for protecting cornea
SMT202300229T1 (it) Composizioni per trattare condizioni oftalmiche
IL252543B (en) Compounds for the treatment of degenerative retinal tissues
PL3849596T3 (pl) Kompozycje do zastosowania w leczeniu chorób oczu zależnych od końcowych produktów zaawansowanej glikacji
IL263336B (en) Compounds for the treatment of symphysiolysis
GB201813783D0 (en) Therapeutic compositions
GB201811726D0 (en) Therapeutic compositions